Medication-assisted treatment billing
Medication-assisted treatment billing describes how claims are prepared for care that combines FDA-approved medications for substance use disorders with counseling and behavioral therapies. Because MAT spans a pharmacologic component, an evaluation and management component, and a psychosocial component, a single course of treatment often generates several distinct billable elements that must be documented, coded, and coordinated together. The specific codes, bundling arrangements, and coverage conditions differ by payer, plan, state Medicaid program, treatment setting, and effective date, so billing teams generally confirm current requirements against the applicable payer policy and authoritative federal guidance rather than assuming a universal rule. MAT can also carry heightened confidentiality obligations that shape how substance-use information travels through the revenue cycle.
Updated 7 min read
Reviewed by Anwaar Tayyab
Director of Billing Operations ·
On this page
Key takeaways
- MAT episodes typically bundle a medication component, a practitioner evaluation-and-management component, and a counseling or behavioral component, each with its own documentation and coding considerations.
- Whether MAT is billed as separate line items, a bundled program rate, or a periodic case-management payment varies by payer, plan, state Medicaid program, and treatment setting.
- Records that would identify a patient as having a substance use disorder, and that were obtained by a federally assisted program for treatment, diagnosis, or referral, are subject to 42 CFR Part 2, and, separately, to HIPAA where the program is a covered entity or business associate; this shapes how such information is disclosed during eligibility, authorization, and claim adjudication.
- Place of service, provider type, and enrollment status all influence how MAT claims are constructed and where they are submitted.
- Rules and payment structures change over time; teams should verify current requirements against CMS and Medicaid.gov guidance, and against SAMHSA's opioid treatment program certification standards, rather than relying on fixed figures.
The components of a MAT episode
Medication-assisted treatment integrates pharmacotherapy with behavioral support, and each part of that integrated model tends to generate a distinct billable concept. Understanding these components helps clarify why a single MAT visit may not map to one line on a claim.
- Medication component
- The FDA-approved medication itself, along with its administration, dispensing, or ordering. Depending on the drug and setting, this may be billed under a medical benefit, a pharmacy benefit, or through a program rate, and the responsible code set and payer differ accordingly.
- Evaluation and management component
- The practitioner encounter for assessment, induction, dose adjustment, and ongoing monitoring, described through the E/M framework used in behavioral health.
- Counseling and behavioral component
- Individual or group counseling and psychotherapy that supports recovery, which may be reported using time-based psychotherapy conventions or group-therapy conventions when applicable.
How these components combine on a claim is not uniform. Some payers expect separate reporting of the medication management and counseling; others recognize bundled MAT program codes or periodic payments that encompass multiple services. The maintained code sets involved are governed by their respective maintainers, and MAT billing draws on more than one of them, so teams confirm the correct reporting convention against current payer policy and the applicable code set. Federal opioid treatment standards are a condition of program certification and govern how a certified program must operate rather than how its claims are coded. Related reporting conventions are covered under substance use disorder billing.
Bundled programs versus separate services
A recurring question in MAT billing is whether services are reported individually or as a bundle. The answer depends on the program model, the payer, and the setting, and the same clinical episode can be billed very differently across two plans.
| Structure | How services are reported | Where variation comes from |
|---|---|---|
| Separately reported services | Medication management, E/M, and counseling each appear as distinct line items with their own documentation. | Payer bundling edits, provider type, and place of service. |
| Bundled program rate | A single code or rate represents a defined set of MAT services delivered over a period. | State Medicaid program design and payer-specific program definitions. |
| Periodic case-management payment | A recurring payment supports care coordination alongside separately billed medication or counseling. | Program eligibility rules and contract terms. |
This table illustrates structural options only; the arrangement that applies to a given claim is set by the specific payer, plan, state program, and contract in effect on the date of service.
Bundling edits vary
Eligibility, authorization, and enrollment
Front-end revenue cycle steps carry particular weight in MAT because coverage for substance use disorder services can sit behind carve-outs and program-specific rules. Confirming benefits before treatment reduces avoidable denials later.
Verify coverage and benefits
Confirm active coverage and the applicable behavioral health benefit through eligibility verification, noting whether substance-use benefits are administered under a behavioral health carve-out.Confirm authorization requirements
Determine whether the medication, the program, or the counseling requires prior authorization, which varies by payer, plan, and medication.Check provider enrollment and network status
Confirm the rendering provider's enrollment and network participation for the relevant program, since MAT may involve program-specific certification in addition to standard billing privileges.
Coverage rules for substance use disorder treatment are also shaped by parity requirements, which limit how differently plans can treat behavioral health relative to medical and surgical benefits. Parity does not translate into a single fixed billing rule, but it informs how authorization and coverage decisions are evaluated.
Setting, place of service, and confidentiality
MAT is delivered across office practices, opioid treatment programs, hospital-based settings, and telehealth, and the setting influences both how a claim is constructed and which claim form applies. Facility-based programs may bill on institutional forms, while professional services are commonly reported on the professional claim format, with institutional billing using the UB-04 where applicable.
Place of service and telehealth conventions carry their own considerations for behavioral health, discussed further under place of service and telehealth. The correct place-of-service reporting depends on where care is furnished and on current payer telehealth policy, which has shifted over time.
Confidentiality shapes the revenue cycle
Documentation and denial prevention
Because MAT combines multiple services, documentation must support each billed element independently. Notes that clearly distinguish medication management from counseling, and that establish medical necessity for the level of care, reduce the risk of downstream adjustments.
- Distinct documentation for the medication management encounter and any separately reported counseling.
- Support for the time or complexity that justifies the reported service level, consistent with behavioral health documentation requirements.
- Alignment between authorized units and billed services to avoid authorization-related denials.
- Attention to timely filing windows, which differ by payer and program.
When claims are denied, the reason codes on the remittance advice guide corrective action, and recurring patterns are analyzed through the lens of common behavioral health denials. Effective coordination of benefits also matters when patients hold more than one coverage source.
Note
Frequently asked questions
Is medication-assisted treatment billed as one service or several?
It depends on the payer, plan, state program, and setting. Some arrangements report the medication component, the practitioner evaluation and management, and the counseling separately, while others use a bundled program rate or a periodic payment. The applicable structure is confirmed against current payer policy rather than assumed.
Does 42 CFR Part 2 apply to every substance use disorder claim?
Part 2 governs records that would identify a patient as having a substance use disorder and that were obtained by a federally assisted program for treatment, diagnosis, or referral, so its limits apply when a provider or program falls under that definition rather than to all substance-use information universally. HIPAA applies separately, to covered entities and their business associates. Whether Part 2 applies to a given program, and how consent is handled, is confirmed against the current regulation and program status.
Do MAT medications require prior authorization?
It varies by payer, plan, and the specific medication and setting. Some plans require authorization for a medication, a program, or a level of care, while others do not. Because these requirements change over time, they are verified against current payer policy before treatment.
Related glossary terms
Definitions that frequently arise when reviewing medication-assisted treatment billing.
Related reading
Continue exploring behavioral health and substance-use billing topics.
Substance use disorder billing
How claims are prepared for the broader category of substance use disorder treatment.
Billing for medication management
Reporting conventions for the practitioner medication-management encounter.
Confidentiality and 42 CFR Part 2
How substance-use confidentiality rules affect the revenue cycle.
Behavioral health parity
How parity requirements shape coverage of behavioral health services.
Behavioral health eligibility and carve-outs
Verifying benefits when behavioral health is administered separately.
Authoritative sources
- 42 CFR 410.67 — Medicare coverage and payment of opioid use disorder treatment services furnished by opioid treatment programs (opens in a new tab)
eCFR. The regulation behind the bundled MAT structure. Defines an episode of care as a one-week period and lists the opioid use disorder treatment services a program may furnish within it, including FDA-approved opioid agonist and antagonist medications, their dispensing and administration, substance use counseling, individual and group therapy, toxicology testing, intake activities, and periodic assessments. Requires the program to be enrolled in Medicare, to hold a certification from the Substance Abuse and Mental Health Services Administration, to be accredited by a SAMHSA-approved accrediting body, and to have a provider agreement in effect, and sets the bundled payment as a drug component plus a non-drug component.
- 42 CFR 8.12 — Federal opioid use disorder treatment standards (opens in a new tab)
eCFR. The Substance Abuse and Mental Health Services Administration standards an opioid treatment program must meet as a condition of certification. Requires the program to provide adequate medical, counseling, vocational, educational, and other screening, assessment, and treatment services to meet patient needs, with the combination and frequency of services tailored to each patient's individualized assessment and care plan; requires an initial medical examination in two parts and periodic assessments; and requires counselors and other licensed or certified providers to meet the credentialing and licensure requirements of their own professions.
- 42 CFR 2.12 — Applicability of the substance use disorder patient record confidentiality rules (opens in a new tab)
eCFR. Scopes 42 CFR Part 2 to records that would identify a patient as having or having had a substance use disorder and that contain substance use disorder information obtained by a federally assisted program for the purpose of treating that disorder, diagnosing it for treatment, or making a referral for treatment. Defines federal assistance to include participating as a Medicare provider and holding a registration to dispense a controlled substance used in treating substance use disorders, and sets the exceptions, including communications within a part 2 program and communications with a qualified service organization.
- 42 CFR 2.33 — Uses and disclosures permitted with written consent (opens in a new tab)
eCFR. The consent rule behind the payment path this article describes. Permits a part 2 program to use and disclose records in accordance with a patient consent that meets the written-consent requirements of 42 CFR 2.31, and provides that where the patient gives a single consent for all future uses and disclosures for treatment, payment, and health care operations, a part 2 program, covered entity, or business associate may use and disclose those records for treatment, payment, and health care operations as the HIPAA regulations permit, until the patient revokes that consent in writing. Also sets the limits on further disclosure by recipients, including lawful holders that are not covered entities or business associates.
- Opioid Treatment Programs (OTP) — Billing & Payment (opens in a new tab)
Centers for Medicare & Medicaid Services. The Medicare billing instructions for opioid treatment programs. States that Medicare pays enrolled programs bundled payments based on weekly episodes of care; that institutional providers bill on the Form CMS-1450 using program-specific type-of-bill codes, a condition code for provider-based programs, and revenue codes, with an opioid use disorder diagnosis on all program services; and that professional providers bill on the Form CMS-1500 using place of service code 58 for a non-residential opioid treatment facility, the HCPCS code for the service, and the organizational NPI as the billing provider.
- Substance Use Disorders Resources (opens in a new tab)
Medicaid.gov (CMS). The federal resource page behind the state-by-state variation this article describes. Records that many states have included behavioral health services for individuals with a substance use disorder in their Medicaid state plans, managed care waivers, and section 1115 demonstrations, and collects the State Health Official and State Medicaid Director letters on mandatory Medicaid state plan coverage of medication-assisted treatment, including its permanent extension.